Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial †
Titel:
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial †
Auteur:
Yoon, H.H. Bendell, J.C. Braiteh, F.S. Firdaus, I. Philip, P.A. Cohn, A.L. Lewis, N. Anderson, D.M. Arrowsmith, E. Schwartz, J.D. Gao, L. Hsu, Y. Xu, Y. Ferry, D. Alberts, S.R. Wainberg, Z.A.